Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Amanda Wieland

Concepts (70)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Non-alcoholic Fatty Liver Disease
6
2021
245
1.630
 Why?
Liver Transplantation
2
2018
707
0.750
 Why?
Hypertension, Portal
1
2021
61
0.710
 Why?
Liver Diseases, Alcoholic
1
2018
81
0.570
 Why?
Hepatitis C
1
2018
219
0.490
 Why?
Dysbiosis
1
2015
146
0.450
 Why?
Diabetes Complications
1
2015
211
0.420
 Why?
Specialization
1
2013
115
0.410
 Why?
Hepatitis C, Chronic
3
2021
151
0.410
 Why?
Intestines
1
2015
326
0.400
 Why?
Physicians, Primary Care
2
2018
222
0.380
 Why?
Fatty Liver
1
2013
210
0.370
 Why?
Patient Education as Topic
1
2015
680
0.350
 Why?
Hepacivirus
4
2021
229
0.330
 Why?
Disease Management
1
2013
560
0.330
 Why?
Antiviral Agents
3
2021
645
0.320
 Why?
Microbiota
1
2015
647
0.300
 Why?
Health Knowledge, Attitudes, Practice
1
2015
1183
0.270
 Why?
Practice Patterns, Physicians'
1
2013
1177
0.240
 Why?
Obesity
2
2021
2508
0.220
 Why?
Simeprevir
2
2017
8
0.180
 Why?
Interferons
1
2021
151
0.180
 Why?
Sofosbuvir
2
2017
54
0.170
 Why?
Single-Cell Analysis
1
2021
188
0.170
 Why?
Liver Cirrhosis
1
2021
227
0.160
 Why?
T-Lymphocyte Subsets
1
2021
383
0.160
 Why?
Waiting Lists
1
2018
211
0.140
 Why?
Protease Inhibitors
1
2017
97
0.130
 Why?
Drug Costs
1
2017
92
0.130
 Why?
Transcriptome
1
2021
725
0.130
 Why?
Drug Interactions
1
2017
338
0.130
 Why?
Risk Factors
4
2021
8632
0.120
 Why?
Metagenome
1
2015
122
0.120
 Why?
Humans
11
2021
114662
0.120
 Why?
Models, Animal
1
2015
344
0.110
 Why?
Surveys and Questionnaires
2
2015
4622
0.100
 Why?
Gene Expression Regulation
1
2021
2319
0.100
 Why?
Prevalence
2
2021
2251
0.100
 Why?
Education, Medical, Continuing
1
2013
117
0.100
 Why?
Body Mass Index
2
2021
1958
0.100
 Why?
Data Collection
1
2013
620
0.090
 Why?
United States
2
2018
12181
0.090
 Why?
Treatment Outcome
3
2018
9088
0.080
 Why?
Female
6
2018
59493
0.080
 Why?
Middle Aged
4
2017
26733
0.070
 Why?
Insulin Resistance
1
2015
1072
0.070
 Why?
Male
6
2021
55583
0.070
 Why?
Adult
3
2017
30544
0.060
 Why?
Drug Therapy, Combination
2
2017
951
0.060
 Why?
Aged
2
2017
19069
0.040
 Why?
Sustained Virologic Response
1
2017
33
0.040
 Why?
Models, Economic
1
2017
48
0.030
 Why?
Pharmacy
1
2017
28
0.030
 Why?
Outpatient Clinics, Hospital
1
2017
79
0.030
 Why?
Remission Induction
1
2017
233
0.030
 Why?
Life Style
1
2018
430
0.030
 Why?
Ribavirin
1
2017
89
0.030
 Why?
Analgesics
1
2017
158
0.030
 Why?
Diagnosis, Differential
1
2018
1342
0.030
 Why?
Pharmacists
1
2017
233
0.030
 Why?
Cost-Benefit Analysis
1
2017
544
0.030
 Why?
Animals
1
2015
31699
0.030
 Why?
Weight Loss
1
2018
642
0.030
 Why?
Genotype
1
2017
1760
0.020
 Why?
Biomarkers
1
2021
3408
0.020
 Why?
Liver
1
2018
1637
0.020
 Why?
Prospective Studies
1
2021
6219
0.020
 Why?
Primary Health Care
1
2018
1512
0.020
 Why?
Colorado
1
2017
4099
0.020
 Why?
Retrospective Studies
1
2017
12546
0.010
 Why?
Wieland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (70) concept(s)
_
Co-Authors Expand Description
See all (13) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)